 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | JNJ-64991524 / J&J
Trial completion: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (clinicaltrials.gov) - Jan 24, 2019
P1, N=86, Completed, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed
- | JNJ-64991524 / J&J
Trial primary completion date: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (clinicaltrials.gov) - Aug 9, 2018
P1, N=84, Recruiting, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed Trial primary completion date: Jul 2018 --> Dec 2018
- | JNJ-64991524 / J&J
Trial completion date: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (clinicaltrials.gov) - Mar 3, 2018
P1, N=96, Recruiting, Sponsor: Janssen Research & Development, LLC
Trial primary completion date: Jul 2018 --> Dec 2018 Trial completion date: Oct 2018 --> Dec 2018
- ||| JNJ-64991524 / J&J
Enrollment open: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (clinicaltrials.gov) - Nov 29, 2017
P1, N=96, Recruiting, Sponsor: Janssen Research & Development, LLC
Trial completion date: Oct 2018 --> Dec 2018 Not yet recruiting --> Recruiting
- ||| JNJ-64991524 / J&J
New P1 trial: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants (clinicaltrials.gov) - Nov 17, 2017
P1, N=96, Not yet recruiting, Sponsor: Janssen Research & Development, LLC